Back to results
US 2022/0202879 A1Published application
Compositions and methods of treating asthma
AssigneesThe Jackson Laboratory, Washinton University
InventorsYanjiao Zhou, Avraham Beigelman, Leonard Bacharier, George Weinstock
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods and compositions utilizing upper-airway microbiota for diagnosing individuals at risk for asthma exacerbations. Further provided herein are probiotic compositions and methods for treating asthma by administering microorganisms that are associated with decreased risk of asthma exacerbations.
Claims21
1-116. (canceled)
A method comprising:
- administering to an individual a composition comprising, or a bacterial extract obtained from, Corynebacterium microorganisms and Dolosigranulum microorganisms at a dose sufficient to increase a proportion of the Corynebacterium microorganisms and Dolosigranulum microorganisms in the nasal microbiota of the individual, relative to a proportion of Moraxella, Staphylococcus, and/or Streptococcus microorganisms in the nasal microbiota of the individual, wherein the individual has asthma or early signs of loss of asthma control.
A method comprising:
- assaying a biological sample obtained from an individual for a proportion of Corynebacterium microorganisms and Dolosigranulum microorganisms, wherein the individual has asthma or early signs of loss of asthma control;
- and
- administering a therapy to the individual.
A method comprising:
- acquiring a biological sample from an upper airway of an individual with early signs of loss of asthma control;
- assaying an amount, concentration, or proportion of Corynebacterium microorganisms and Dolosigranulum microorganisms in the biological sample.
Dependencies are inferred from the claim text.